This announcement is a separate document:
卫信康:西藏卫信康医药股份有限公司2022年第三季度报告
Wei Xinkang: Report of Tibet Weixinkang Pharmaceutical Co., Ltd. for the third quarter of 2022
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.